{"id":5417,"date":"2021-09-08T11:47:00","date_gmt":"2021-09-08T09:47:00","guid":{"rendered":"https:\/\/saccosystem.com\/?post_type=news&p=5417"},"modified":"2024-12-11T16:32:52","modified_gmt":"2024-12-11T15:32:52","slug":"sacco-system-to-support-breakthrough-research-on-infant-gut-health-with-evivo-the-baby-probiotic","status":"publish","type":"news","link":"https:\/\/saccosystem.com\/es\/news\/sacco-system-to-support-breakthrough-research-on-infant-gut-health-with-evivo-the-baby-probiotic\/","title":{"rendered":"Sacco System to Support Breakthrough Research on Infant Gut Health with Evivo\u00ae, the Baby Probiotic"},"content":{"rendered":"\n
\n
\n

Evolve BioSystems, Inc. is the manufacturer of Evivo\u00ae, a proprietary groundbreaking probiotic proven to resolve Newborn Gut Deficiency, which studies have shown affects more than 90% of babies in the U.S. Evivo contains activated B. infantis EVC001 which restores key bacteria to the infant’s gut and guides critical development of infant’s digestive and immune system. Evivo works by favourably altering gut biochemistry to reduce potentially pathogenic bacteria by 80 per cent which in turn significantly reduces intestinal inflammation. Those pathogens and the inflammation which they cause are linked to a higher risk of both short- and long-term health issues including colic, diaper rash, eczema, asthma, allergies and even Type 1 Diabetes. <\/p>\n\n\n\n

Martino Verga, CEO Sacco System<\/strong>
\u201cWe are impressed by the science that Evolve has done, and are excited to be within the European investors in Evolve. We believe in the mission of Evolve because our company CSL was the first company in Italy to study Lactic Acid Bacteria for human health.
One of Sacco System pillars is creative intelligence, with a focus on R&D and innovation. For this reason, we are proud to be a partner with Evolve, a company dedicated to developing the next generation of probiotics to improve life and wellbeing.
We strongly trust that there is always a probiotic that makes your life better\u201d.
Sacco System and its reputation as a highly professional manufacturer of probiotics and other live biotherapeutics will support an investment that will help Evolve BioSystems, Inc in bringing Evivo\u00ae Baby Probiotic to Europe. <\/p>\n\n\n\n

Tim Brown, CEO Evolve BioSystems, Inc.<\/strong>
\u201cWe are pleased to add Sacco to the growing list of investors in Evolve\u201d said Tim Brown, CEO of Evolve BioSystems, \u201cThis investment from major Italian corporations signals the interest in Evolve\u2019s proprietary product lines on a global Basis\u201d.<\/p>\n\n\n\n

<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n

\n
\n
\n

\n Latest News <\/h2>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n 19 marzo 2026 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505\u00ae receives GRAS status <\/div>\n
\n <\/div>\n
\n

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505\u00ae HI.<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 22 diciembre 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System crece en Am\u00e9rica Latina: adquiere BioInsumos en Uruguay y Sacco Brasil <\/div>\n
\n <\/div>\n
\n

El grupo acelera su estrategia de desarrollo en Sudam\u00e9rica mediante una doble operaci\u00f3n: la adquisici\u00f3n de una empresa uruguaya y la integraci\u00f3n total de su filial brasile\u00f1a. El grupo apunta<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 11 diciembre 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System presenta PerforMilk\u00ae: aprovechar todo el potencial de la leche preservando la calidad proteica <\/div>\n
\n <\/div>\n
\n

La leche es el recurso m\u00e1s valioso en la producci\u00f3n l\u00e1ctea.Solo es posible obtener productos de alta calidad a partir de leche de alta calidad, y en el panorama actual,<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 20 noviembre 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME\u00ae model <\/div>\n
\n <\/div>\n
\n

\u201cSurvivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME\u00ae model\u201d is the title of the study that has been<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 07 febrero 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health <\/div>\n
\n <\/div>\n
\n

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 08 enero 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System Australia\u2019s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ <\/div>\n
\n <\/div>\n
\n

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 25 noviembre 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Our 2023 sustainability report is online! <\/div>\n
\n <\/div>\n
\n

Our commitment to sustainability: a review of an evolving journey We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 16 abril 2024 <\/div>\n
\n News <\/div>\n <\/div>\n
\n
\n Sacco System is pleased to announce the grand opening of its development site in Australia. <\/div>\n
\n <\/div>\n
\n

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 26 marzo 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System companies have been awarded as Sustainability champions by Ecovadis <\/div>\n
\n <\/div>\n
\n

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 18 marzo 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n List Biotherapeutics and Sacco System Announce Lead Share Agreement <\/div>\n
\n <\/div>\n
\n

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 \u2013 List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 26 febrero 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n CSL FRANCE becomes SACCO SYSTEM FRANCE <\/div>\n
\n <\/div>\n
\n

Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries, based on tradition, expertise, research, and innovation which sells and distributes its ingredients in more<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 21 febrero 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System Supports Action4Diabetes’ mission <\/div>\n
\n <\/div>\n
\n

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission\u2014a UK-based charity committed to ensuring free access to crucial medical supplies,<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Read Article <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Evolve BioSystems, Inc. is the manufacturer of Evivo\u00ae, a proprietary groundbreaking probiotic proven to resolve Newborn Gut Deficiency, which studies have shown affects more than 90% of babies in the<\/p>\n","protected":false},"featured_media":3117,"template":"","meta":{"_acf_changed":false},"category_news":[],"tag_news":[],"class_list":["post-5417","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/news\/5417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/media\/3117"}],"wp:attachment":[{"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/media?parent=5417"}],"wp:term":[{"taxonomy":"category_news","embeddable":true,"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/category_news?post=5417"},{"taxonomy":"tag_news","embeddable":true,"href":"https:\/\/saccosystem.com\/es\/wp-json\/wp\/v2\/tag_news?post=5417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}